Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,988.00
Bid: 12,016.00
Ask: 12,020.00
Change: -38.00 (-0.32%)
Spread: 4.00 (0.033%)
Open: 12,070.00
High: 12,144.00
Low: 11,882.00
Prev. Close: 12,026.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1 Feb 2022 13:22

Spanish Covid-19 vaccine shows high efficacy against Omicron variants

(Sharecast News) - The Covid-19 vaccine being developed by Spain's Hipra has shown a "high efficacy" against the new Omicron variants and is now entering third phase clinical trials.

Read more
31 Jan 2022 10:58

Omicron subvariant is 1.5 times more transmissible than original

(Sharecast News) - A new Omicron subvariant known is more transmissible than its forebear which first appeared in South Africa, scientists said at the weekend, although some studies have shown that vaccines are more effective against it.

Read more
31 Jan 2022 09:23

UPDATE 2-FTSE 100 ends flat as healthcare, commodity-linked stocks weigh; ends month higher

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Vodafone among top FTSE 100 gainers* Recruiter SThree gains after annual profit doubles* Online estate agency Purplebricks forecasts growth...

Read more
29 Jan 2022 12:02

UPDATE 1-AstraZeneca China summoned over suspected fraud

(Adds detail, AstraZeneca comment, paragraphs 7,8)BEIJING, Jan 29 (Reuters) - Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company's employees, the National Heal...

Read more
25 Jan 2022 09:57

LONDON BROKER RATINGS: Credit Suisse likes Hargreaves Lansdown, abrdn

LONDON BROKER RATINGS: Credit Suisse likes Hargreaves Lansdown, abrdn

Read more
25 Jan 2022 09:31

Germany to receive 3.8 mln doses of Novavax's new COVID vaccine in Q1

BERLIN, Jan 25 (Reuters) - Germany expects to receive 3.8 million doses of Novavax's newly approved COVID-19 vaccine Nuvaxovid by March 20, the health ministry said on Tuesday, as the government looks to persuade unvaccinated Germans to get a sho...

Read more
24 Jan 2022 14:27

European Medicines Agency panel approves scaling up AstraZeneca COVID vaccine production

Jan 24 (Reuters) - A panel of the European drug regulator on Monday approved scaling up manufacturing of AstraZeneca's COVID-19 vaccine.An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling lin...

Read more
24 Jan 2022 12:13

Morgan Stanley reiterates 'buy' for FTSE 100, highlights 'defensive' qualities

(Sharecast News) - Analysts at Morgan Stanley sounded a 'bullish' note on the outlook for the FTSE 100, highlighting its greater 'defensive' properties relative to rivals, higher dividend yields versus global peers, exposure to energy and record low expectations for growth in the profits of its constituent companies.

Read more
19 Jan 2022 08:47

AstraZeneca Imfinzi's shows positive results in liver cancer treatment

AstraZeneca Imfinzi's shows positive results in liver cancer treatment

Read more
19 Jan 2022 07:55

AstraZeneca reports positive results from Imfinzi trials

(Sharecast News) - AstraZeneca on Wednesday said its Imfinzi drug combined with chemotherapy reduced the risk of death by 20% in people with advanced biliary tract cancer (BTC) after results from a phase III clinical trial.

Read more
19 Jan 2022 06:00

AstraZeneca posts robust results for Imfinzi as tract cancer treatment

AstraZeneca posts robust results for Imfinzi as tract cancer treatment

Read more
18 Jan 2022 16:34

UPDATE 1-EU watchdog urges vaccine developers not to focus only on Omicron

* Pharma groups have been working on upgraded Omicron vaccines* BioNTech CEO has questioned merit of multipurpose shot (Adds background, BioNTech remarks)By Ludwig Burger and Pushkala AripakaJan 18 (Reuters) - The European Union drugs regulator sai...

Read more
17 Jan 2022 07:38

AstraZeneca's Enhertu granted priority review by US FDA

(Sharecast News) - Drugmaker AstraZeneca said on Monday that its Daiichi Sankyo collaboration Enhertu had been granted priority review by the Federal Drug Administration in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen.

Read more
13 Jan 2022 10:54

TOP NEWS: New AstraZeneca vaccine results show strong effect on Covid

TOP NEWS: New AstraZeneca vaccine results show strong effect on Covid

Read more
13 Jan 2022 08:24

LONDON BRIEFING: AIM giant ASOS to move to London Main Market

LONDON BRIEFING: AIM giant ASOS to move to London Main Market

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.